Northeast Pharmaceutical Group Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Northeast Pharmaceutical Group.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 18.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597) Soars 27% But It's A Story Of Risk Vs Reward
Nov 08Northeast Pharmaceutical Group's (SZSE:000597) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 30It's A Story Of Risk Vs Reward With Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597)
Aug 07These 4 Measures Indicate That Northeast Pharmaceutical Group (SZSE:000597) Is Using Debt Safely
May 25Northeast Pharmaceutical Group (SZSE:000597) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Apr 05In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Northeast Pharmaceutical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 7,973 | 347 | 494 | 689 | N/A |
6/30/2024 | 7,905 | 380 | 453 | 676 | N/A |
3/31/2024 | 7,829 | 346 | 318 | 567 | N/A |
12/31/2023 | 8,243 | 358 | 351 | 587 | N/A |
9/30/2023 | 8,643 | 442 | 518 | 762 | N/A |
6/30/2023 | 8,895 | 373 | 683 | 927 | N/A |
3/31/2023 | 8,810 | 352 | 755 | 961 | N/A |
1/1/2023 | 8,809 | 350 | 864 | 1,109 | N/A |
9/30/2022 | 8,609 | 202 | 771 | 979 | N/A |
6/30/2022 | 8,555 | 151 | 856 | 1,018 | N/A |
3/31/2022 | 8,478 | 129 | 861 | 1,028 | N/A |
12/31/2021 | 8,145 | 99 | 627 | 747 | N/A |
9/30/2021 | 8,003 | 37 | 411 | 548 | N/A |
6/30/2021 | 7,671 | 14 | 366 | 590 | N/A |
3/31/2021 | 7,465 | 71 | 397 | 816 | N/A |
12/31/2020 | 7,384 | 12 | 171 | 571 | N/A |
9/30/2020 | 7,659 | -1 | 582 | 990 | N/A |
6/30/2020 | 7,833 | 113 | 361 | 717 | N/A |
3/31/2020 | 8,026 | 97 | 42 | 234 | N/A |
12/31/2019 | 8,220 | 174 | 123 | 353 | N/A |
9/30/2019 | 7,898 | 214 | -390 | 123 | N/A |
6/30/2019 | 7,828 | 198 | -390 | 95 | N/A |
3/31/2019 | 7,622 | 200 | -331 | 209 | N/A |
12/31/2018 | 7,467 | 195 | -281 | 285 | N/A |
9/30/2018 | 7,102 | 196 | -556 | -207 | N/A |
6/30/2018 | 6,659 | 196 | N/A | -117 | N/A |
3/31/2018 | 6,204 | 160 | N/A | -478 | N/A |
12/31/2017 | 5,676 | 119 | N/A | -301 | N/A |
9/30/2017 | 5,271 | 98 | N/A | 279 | N/A |
6/30/2017 | 5,176 | 60 | N/A | 104 | N/A |
3/31/2017 | 5,016 | 39 | N/A | 540 | N/A |
12/31/2016 | 4,814 | 24 | N/A | 385 | N/A |
9/30/2016 | 4,581 | -156 | N/A | 255 | N/A |
6/30/2016 | 4,122 | -295 | N/A | 301 | N/A |
3/31/2016 | 4,031 | -358 | N/A | 108 | N/A |
12/31/2015 | 3,834 | -384 | N/A | 100 | N/A |
9/30/2015 | 4,006 | -194 | N/A | -81 | N/A |
6/30/2015 | 4,092 | -77 | N/A | -17 | N/A |
3/31/2015 | 4,223 | -8 | N/A | 19 | N/A |
12/31/2014 | 4,333 | 87 | N/A | 47 | N/A |
9/30/2014 | 4,260 | -27 | N/A | -59 | N/A |
6/30/2014 | 4,199 | -56 | N/A | -178 | N/A |
3/31/2014 | 4,022 | -77 | N/A | -215 | N/A |
12/31/2013 | 3,871 | -167 | N/A | -266 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 000597's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 000597's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 000597's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 000597's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 000597's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 000597's Return on Equity is forecast to be high in 3 years time